| Literature DB >> 21914199 |
Muneharu Yamazaki1, Tao Wu, Satyanarayana R Pondugula, Donald G Harbidge, Daniel C Marcus.
Abstract
BACKGROUND: Sodium absorption by semicircular canal duct (SCCD) epithelial cells is thought to contribute to the homeostasis of the volume of vestibular endolymph. It was previously shown that the epithelial cells could absorb Na+ under control of a glucocorticoid hormone (dexamethasone) and the absorptive transepithelial current was blocked by amiloride. The most commonly-observed target of amiloride is the epithelial sodium channel (ENaC), comprised of the three subunits α-, β- and γ-ENaC. However, other cation channels have also been observed to be sensitive in a similar concentration range. The aim of this study was to determine whether SCCD epithelial cells absorb only Na+ or also K+ through an amiloride-sensitive pathway. Parasensory K+ absorption could contribute to regulation of the transduction current through hair cells, as found to occur via vestibular transitional cells [S. H. Kim and D. C. Marcus. Regulation of sodium transport in the inner ear. Hear.Res. doi:10.1016/j.heares.2011.05.003, 2011].Entities:
Year: 2011 PMID: 21914199 PMCID: PMC3180474 DOI: 10.1186/1756-0500-4-355
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Figure 1Short circuit current (I. A) Representative traces. Basolateral solution was physiological saline and apical solution was either Na+-rich (left) or K+-rich (right). Note break in time axis; Isc of each culture insert was measured in each apical solution using different order of exposure and washing in between measurements. Amiloride (100 μM) added on the apical side as indicated by horizontal red bar. B) Summary of normalized currents from experiments as in A.
SCCD transepithelial and cellular currents
| Na+-rich | K+-rich | ||||
|---|---|---|---|---|---|
| control | amiloride | control | amiloride | ||
| permeable | Ussing chamber | 6.16 ± 0.83 (9) | 1.00 ± 0.34 (9)* | 1.71 ± 0.26 (12) | 1.17 ± 0.3 (12) ns |
| Whole cell patch | -60.8 ± 20.3 (9) | -36.3 ± 17.3 (9)* | -3.8 ± 0.1 (5) | -3.6 ± 0.3 (5) ns | |
| impermeable | Whole cell patch | -137.6 ± 68.7 (6) | -127.9 ± 64.2 (6) ns | -69.6 ± 6.1 (7) | -64.0 ± 5.7 (7)* |
Table entries are means ± SEM (number of experiments).
Isc : short circuit current (μA/cm2), I-120 mV : whole-cell patch clamp current at -120 mV command voltage (pA/pF)
Amilorde concentration was 100 μM for all experiments.
Significant differences: *, P < 0.05; ns, not significant.
Comparisons: Values in amiloride vs control (without amiloride) using the paired t-test.
Figure 2Representative whole-cell patch clamp recordings and current-voltage curves from SCCD epithelial cells grown on permeable supports. Left panel, Na+ -rich bath and pipette, Right panel, K+-rich bath and pipette. The holding potential and voltage command protocol are illustrated. Amiloride concentration was 100 μM. Bottom: Representative current-voltage relationships of the whole cell currents in the presence and absence of amiloride (100 μM). Voltages are corrected for the liquid junction potentials (see Methods).
Figure 3Summary of current-voltage relationships of amiloride-sensitive currents on permeable and impermeable supports. Summary of current-voltage relationships in terms of amiloride-sensitive currents measured in Na+-rich bath solution and K+-rich bath solution from SCCD epithelial cells grown on (A) permeable supports and (B) impermeable supports. Voltages are corrected for the liquid junction potentials (see Methods). I, amil-sens, amiloride-sensitive currents (pA/pF).
Figure 4Summary of whole-cell patch clamp currents with only Na. Bar graph of the currents at -120 mV in Na+ -rich solution and K+-rich solutions. Amiloride-sensitive currents were only observed in Na+ -rich solution.
Amiloride sensitive channels
| name | gene bank | gene | amiloride, IC50, μM | cation selectivity, PNa/PK | gene array*, DEX (GEO, GSE6197) | reference |
|---|---|---|---|---|---|---|
| α-ENaC | Scnn1a | 0.17 | 1 | P | [ | |
| αβ-ENaC | Scnn1b | 4 | ≥ 100 | P | [ | |
| αγ-ENaC | Scnn1g | 0.13 | ≥ 100 | P | [ | |
| αβγ-ENaC | 0.1 | ≥ 100 | P | [ | ||
| ASIC2a | Accn1 | 28 | ≥ 10 | A | [ | |
| ASIC1a | Accn2 | 10 | 6-13 | P | [ | |
| CNGA1 | Ccng1 | (100 tested)** | 1 | P | [ | |
| CNGA2 | Cncg4 | ND | 1 | A | [ | |
| CNGA3 | Cnga3 | ND | 1 | A | [ | |
| HCN1 | Hcn1 | ND | 0.3 | P | [ | |
| HCN2 | Hcn2 | ND | 0.3 | A | [ | |
| HCN3 | Hcn3 | ND | 0.3 | P | [ | |
| HCN4 | Hcn4 | ND | 0.3 | A | [ | |
| TRPV1 | Trpv1 | Insens | NSC | A | [ | |
| TRPV2 | Vrl1 | ND | NSC | A | [ | |
| TRPV4 | Trpv4 | ND | NSC | A | [ | |
| TRPV6 | Trpv6 | ND | NSC | A | [ |
* gene was detected as present (P) or absent (A) in the presence of 100 nM dexamethasone.
** CNGA1 channels were not inhibited by 100 μM amiloride.
Insens, insensitive; ND, not determined; NSC, non-selective cation channels.